The latest quarterly R&D expense is $7.11 Million with a QoQ Growth of +82.62%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-07-31).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-07-31): $7.11M.
$7.11M
$7.11 Million
Q2 FY2026 · 2026-07-31
+82.62%
vs. $3.90M prior quarter
10
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-07-31 | $7.11M | +82.62% | +41.75% |
| Q1 FY2026Period end 2026-04-30 | $3.90M | -43.37% | -31.81% |
| Q4 FY2025Period end 2026-01-31 | $6.88M | +12.09% | +91.37% |
| Q3 FY2025Period end 2025-10-31 | $6.14M | +22.28% | +59.29% |
| Q2 FY2025Period end 2025-07-31 | $5.02M | -12.15% | +62.13% |
| Q1 FY2025Period end 2025-04-30 | $5.71M | +58.93% | +89.77% |
| Q4 FY2024Period end 2025-01-31 | $3.59M | -6.70% | N/A |
| Q3 FY2024Period end 2024-10-31 | $3.85M | +24.46% | N/A |
| Q2 FY2024Period end 2024-07-31 | $3.10M | +2.82% | N/A |
| Q1 FY2024Period end 2024-04-30 | $3.01M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.